SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Attention is centered on the broader nuclear/SMR theme, with traders speculating that U.S. military microreactor initiatives, pro-nuclear policy and AI data-center power demand could benefit NNE, alongside UAE discussions and company development milestones. Bulls see these as validation of NNEs microreactor strategy, while bears point to sector-wide analyst repricing, its pre-revenue status, dilution risk and sharp recent selloffs.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA approval of Revolution Medicines Rasonque (daraxonrasib), an oral RAS-targeted therapy for metastatic pancreatic cancer, is driving attention after pivotal data showed a substantial survival benefit versus chemotherapy. Traders are debating the muted or negative share-price reaction, with bullish views focused on commercial potential and broader oncology applications while others cite valuation, drug access, side effects, and sell-the-news profit taking.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

Geopolitical headlines around the Iran conflict, Strait of Hormuz access, and potential peace or supply agreements are driving volatile crude-oil expectations and attention to SCOs inverse exposure. Traders are split between betting on de-escalation, rising production, and weaker demand to push oil lower, and warning that continued disruptions could keep crude elevated; many also debate SCOs daily reset and decay, which can limit tracking over time.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A disclosed bearish short report criticizing SELLASs REGAL Phase 3 design, historical controls, dilution and valuation drove the sharp selloff, despite no new adverse company or trial data. Traders remain divided ahead of the 80th-event update and topline readout, with bulls dismissing the report while bears cite the prolonged delay and binary trial risk.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Ongoing U.S.-Iran tensions and uncertainty over Strait of Hormuz shipping are driving attention to crude oil and UCO, with traders reacting to shifting ceasefire and reopening expectations. The community is divided between bulls anticipating supply disruptions and shortages and bears pointing to oversupply, rising inventories, recovering flows, and weaker demand.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

U.S. restrictions on foreign-made, particularly Chinese, connected power inverters are driving attention, with traders viewing Enphases domestic manufacturing as a potential competitive and supply-chain tailwind. Skeptics argue the policy may have limited direct impact because Enphase already operates in the U.S., while weak residential demand, interest-rate sensitivity, and broader solar-sector weakness remain significant headwinds.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Speculation around increased LUNC burnsthrough Market Module 2.0, Binance fee burns, and possible court-related token destructionis driving attention, with traders linking supply reduction to a potential USTC repeg and broader Terra Classic recovery. The community is divided between bullish holders expecting ecosystem momentum and bears citing the tokens large supply, weak liquidity, and repeated failed rallies.

Cash Cat

Robinhoods listing and promotion of Cash Cat have made it a focal point as traders frame it as the flagship meme token of the Robinhood ecosystem, citing its launchpad role, fee-funded buybacks and token burns. Bullish traders are accumulating on pullbacks and comparing it with major meme coins, while skeptics point to the post-listing selloff, high Robinhood spreads and speculative risks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Managements profitability and plan to use Orladeyo cash flow for additional rare-disease acquisitions are driving attention, alongside expectations for navenibart and BCX17725 pipeline progress. Traders remain divided between viewing BioCryst as undervalued and a potential takeover candidate versus concerns about competition from Pharvaris, dilution, and persistently weak price action; takeover speculation is unconfirmed.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScales weak quarterly report and continued concern over share dilution are driving attention, with traders questioning the companys limited commercial progress and lack of binding reactor contracts. Bulls argue the company remains a well-funded, pre-commercial nuclear play with potential TVA/ENTRA1 upside, while bears focus on dilution risk and execution uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


bongdaluhunet

Bongdalu